Larvol Delta - First-US-Patient-Dosed-in-Aulos-Biosciences-Phase-12-Clinical-Trial-of-AU007-a-Novel-IL2-Therapeutic-for-the-Treatment-of-Solid-Tumors

AU-007 - Aulos Biosci

https://www.businesswire.com/news/home/20230201005821/en/First-U.S.-Patient-Dosed-in-Aulos-Bioscience%E2%80%99s-Phase-12-Clinical-Trial-of-AU-007-a-Novel-IL-2-Therapeutic-for-the-Treatment-of-Solid-Tumors

Feb 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next